Back to New Hampshire

SB400 • 2026

relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.

relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.

Healthcare
Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Bill Gannon (R), Howard Pearl (r), Michael Vose (R), Regina Birdsell (R), Liz Barbour (R), Lilli Walsh (R), David Rochefort (R), James Creighton (R)
Last action
2026-05-21
Official status
SENATE
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.

relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.

What This Bill Does

  • relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

Amendment #2026-1309h : AA VV 04/23/2026 HJ 11

Plain English: Amendment #2026-1309h : AA VV 04/23/2026 HJ 11 1

  • The official amendment file could not be read automatically during the last sync, so only the official amendment metadata is shown right now.

Bill History

  1. 2026-05-21 H

    House Refuses to Accede to Senate Request for CofC (Rep. Layon): MA VV 05/21/2026 HJ 14

  2. 2026-05-06 S

    Sen. Pearl Moved Nonconcur with the House Amendment; Requests C of C, MA, VV; (In Recess 04/23/2026); SJ 11

  3. 2026-05-06 S

    President Appoints: Senators Pearl, Gannon, Reardon; (In Recess 04/23/2026); SJ 11

  4. 2026-04-23 H

    Amendment #2026-1309h : AA VV 04/23/2026 HJ 11

  5. 2026-04-23 H

    Ought to Pass with Amendment 2026-1309h: MA VV 04/23/2026 HJ 11

  6. 2026-04-15 H

    Executive Session: 04/08/2026 10:20 am GP 231

  7. 2026-04-15 H

    Committee Report: Ought to Pass with Amendment #2026-1309h 04/08/2026 (Vote 13-1; CC)

  8. 2026-03-18 H

    Public Hearing: 03/25/2026 10:20 am GP 231

  9. 2026-03-10 H

    ==CANCELLED== Public Hearing: 03/19/2026 01:30 pm GP 231

  10. 2026-02-26 H

    Introduced (in recess of) 02/19/2026 and referred to Executive Departments and Administration HJ 5 P. 124

  11. 2026-01-29 S

    SB 400 was Removed from the Consent Calendar; 01/29/2026; SJ 2

  12. 2026-01-29 S

    Committee Amendment #2026-0221s , AA, VV; 01/29/2026; SJ 2

  13. 2026-01-29 S

    Sen. Gannon Floor Amendment #2026-0258s , AA, VV; 01/29/2026; SJ 2

  14. 2026-01-29 S

    Ought to Pass with Amendment s #2026-0221s and #2026-0258s, MA, VV; OT3rdg; 01/29/2026; SJ 2

  15. 2026-01-22 S

    Committee Report: Ought to Pass with Amendment #2026-0221s , 01/29/2026; Vote 4-0; CC; SC 3

  16. 2026-01-15 S

    Hearing: 01/21/2026, Room 103, SH, 09:50 am; SC 2

  17. 2025-11-18 S

    Introduced 01/07/2026 and Referred to Executive Departments and Administration; SJ 1

Official Summary Text

relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.

Current Bill Text

Read the full stored bill text
01/29/2026 0221s
01/29/2026 0258s
23Apr2026... 1309h

2026 SESSION
26-2041
05/06

SENATE BILL
400

AN ACT
relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.

SPONSORS: Sen. Gannon, Dist 23; Sen. Birdsell, Dist 19; Sen. Rochefort, Dist 1; Sen. Pearl, Dist 17; Rep. Barbour, Hills. 35; Rep. Creighton, Hills. 30; Rep. Vose, Rock. 5; Rep. L. Walsh, Rock. 15

COMMITTEE: Executive Departments and Administration

-----------------------------------------------------------------

AMENDED ANALYSIS

This bill requires the annual report by the therapeutic cannabis medical oversight board to include documentation of the board's review of currently approved and additional qualifying medical conditions, including the board's findings and recommendations, and citations to the medical and scientific evidence reviewed by the board.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Explanation: Matter added to current law appears in
bold italics.
Matter removed from current law appears [
in brackets and struckthrough.
]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
01/29/2026 0221s
01/29/2026 0258s
23Apr2026... 1309h 26-2041
05/06

STATE OF NEW HAMPSHIRE

In the Year of Our Lord Two Thousand Twenty-Six

AN ACT
relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.

Be it Enacted by the Senate and House of Representatives in General Court convened:

1 Therapeutic Cannabis Medical Oversight Board; Reporting Requirement. Amend RSA 126-X:12, VI to read as follows:
VI. On or before January 1 of each year, the board shall make a report to the president of the senate, the speaker of the house of representatives, the oversight committee on health and human services established under RSA 126-A:13, the board of medicine, and the board of nursing.
The report shall include documentation of the board's reviews of currently approved and additional qualifying medical conditions, including the board's findings and recommendations, and citations to the medical and scientific evidence reviewed by the board.

2 Effective Date. This act shall take effect 60 days after its passage.